NEYLAN JOHN F. (Chief Medical Officer) sold 0.8% of their position (1.28K shares) of KERYX BIOPHARMACEUTICALS INC on the open market
Open‑market sale worth $4.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/31/2018ACC: 0001114220-18-000086
Officer· Chief Medical Officer
Since Jul 2018
-1.28K
Net shares
Net seller
$4.9K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.28K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.28K
Price / share
$3.86
Trade value
$4.95K
% of position
0.8%
7/30/2018
153.16K→151.87K
Total
Net shares
−1.28K
Net value
-$4.95K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/30/2018 | S · Sale | −1.28K | $3.86 | $4.95K | 0.8% | 153.16K | 151.87K |
| Total | −1.28K | -$4.95K | ||||||
Derivative Transactions0
No derivative transactions reported